Life expectancy: what does it measure?


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
22 07 2020
Historique:
entrez: 24 7 2020
pubmed: 24 7 2020
medline: 17 2 2021
Statut: epublish

Résumé

Life expectancy (LE) is considered a straightforward summary measure of mortality that comes with an implicit age standardisation. Thus, it has become common to present differences in mortality across populations as differences in LE, instead of, say, relative risks. However, most of the time LE does not quite provide what the term promises. LE is based on a synthetic cohort and is therefore not the true LE of anyone. Also, the implicit age standardisation is construed in such a way that it can be questioned whether it standardises age at all. In this paper, we examine LE from the point of view of its applicability to epidemiological and public health research and provide examples on the relation between an LE difference and a relative risk. We argue that the age standardisation in estimations of LE is not straightforward since it is standardised against different age distributions and that the translation of changes in age specific mortality into change in remaining LE will depend on the level and the distribution of mortality in the population. We conclude that LE is not the measure of choice in aetiological research or in research with the aim to identify risk factors of death, but that LE may be a compelling choice in public health contexts. One cannot escape the thought that the mathematical elegance of LE has contributed to its popularity.

Identifiants

pubmed: 32699164
pii: bmjopen-2019-035932
doi: 10.1136/bmjopen-2019-035932
pmc: PMC7380844
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e035932

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ. 2009 Mar 05;338:b688
pubmed: 19264819
Circulation. 2018 Jul 24;138(4):345-355
pubmed: 29712712
BMJ. 2012 Sep 03;345:e5774
pubmed: 22945952
Popul Stud (Camb). 1986 Mar;40(1):147-57
pubmed: 11611920
Demography. 1977 Nov;14(4):411-8
pubmed: 913728

Auteurs

Karin Modig (K)

Institute of Environmental Medicine, Unit of Epidemiology, Karolinska Institutet, Stockholm, Sweden karin.modig@ki.se.

Roland Rau (R)

Max Planck Institute for Demographic Research, Rostock, Germany.

Anders Ahlbom (A)

Institute of Environmental Medicine, Unit of Epidemiology, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH